Blending Stakeholder Perspectives including IDN, Health System & GPO Contracting Decision Makers with Industry Experts Utilizing Advanced Pricing Models to Leverage Risk Agreements & Overcome Transparency Concerns in an Evolving Health Policy Environment
Building on over a decade of educational platform development and delivery through the Annual Q1 Medical Device Strategic Pricing Conference, this upcoming course will provide participants with concentrated educational deliverables focused on creating new pricing structures and pricing models to overcome the challenges health systems are facing, while also trying to make a profit. Given the many challenges faced by the industry; from the shift in the way devices are purchased, paid for and reimbursed, to the migration from a pay-per service to pay-for performance platform, which effects the products purchased and the care provided, device pricing executives will gain tremendous value from interacting with like-minded executives. With an intimate setting of no more than 30 people, we hope industry executives feel comfortable asking for advice, considering new possibilities, and going back to their teams with key takeaways and ideas. While this is ambitious for such a competitive market, we have asked some of the top industry executives to join us as group facilitators, moderating the discussions and posing the “tough’ questions. Hosted in the Bay area in February of 2019, this one-time course will be of great interest to not only those local to the West Coast market, but also participants that were unable to join Q1 at the Charlotte meeting hosted in September 2018.
As participants in this educational meeting, we need to be mindful of the constraints of antitrust laws. For that reason, we must all use our personal judgment to ensure discussions do not infringe on these regulations. This program is a forum for industry leaders to discuss how managed markets and payer support activities can develop and grow in today’s healthcare environment and not to address any proprietary or anti-competitive topics. If you have any questions regarding allowed antitrust behavior, please check with your legal departments.
Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | email@example.com